Compounded (US 503A)· 503A (FDA flagged 2023)
Compounded preparation (US 503A)
Patient-specific preparation from a US 503A pharmacy. Requires a valid prescription and is not an FDA-approved finished drug. Verify the pharmacy's licence and the active ingredient's status on the FDA 503A bulks list.
Empower Pharmacy
Empower Ipamorelin
10 mg lyophilised vial · US — 503A (historical)
Provenance
75n=11
Quality
68n=47
Two independent scores. Never blended into a single number.
Notes
Ipamorelin was placed on Category 2 of the 503A bulks list in 2023.
Active peptide